Integrative omics analyses broaden treatment targets in human cancer.
Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyƶ, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.
Oncogene
Po, A A; Silvano, M M; Miele, E E; Capalbo, C C; Eramo, A A; Salvati, V V; Todaro, M M; Besharat, Z M ZM; Catanzaro, G G; Cucchi, D D; Coni, S S; Di Marcotullio, L L; Canettieri, G G; Vacca, A A; Stassi, G G; De Smaele, E E; Tartaglia, M M; Screpanti, I I; De Maria, R R; Ferretti, E E
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.
Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
The mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order.
Journal Of Experimental & Clinical Cancer Research : Cr
Xie, Guohua G; Xie, Fang F; Wu, Ping P; Yuan, Xiangliang X; Ma, Yanhui Y; Xu, Yunchuan Y; Li, Li L; Xu, Ling L; Yang, Ming M; Shen, Lisong L
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition.
British Journal Of Cancer
Mahoney, C L CL; Choudhury, B B; Davies, H H; Edkins, S S; Greenman, C C; Haaften, G van Gv; Mironenko, T T; Santarius, T T; Stevens, C C; Stratton, M R MR; Futreal, P A PA
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.
Plos One
Marks, Jenifer L JL; McLellan, Michael D MD; Zakowski, Maureen F MF; Lash, Alex E AE; Kasai, Yumi Y; Broderick, Stephen S; Sarkaria, Inderpal S IS; Pham, Duykhanh D; Singh, Bhuvanesh B; Miner, Tracie L TL; Fewell, Ginger A GA; Fulton, Lucinda L LL; Mardis, Elaine R ER; Wilson, Richard K RK; Kris, Mark G MG; Rusch, Valerie W VW; Varmus, Harold H; Pao, William W